Graaf-Rau, Annika https://orcid.org/0000-0002-9590-8550
Schmies, Kathrin
Breithaupt, Angele https://orcid.org/0000-0002-6373-5923
Ciminski, Kevin https://orcid.org/0000-0001-5397-7497
Zimmer, Gert https://orcid.org/0000-0002-2708-2507
Summerfield, Artur
Sehl-Ewert, Julia
Lillie-Jaschniski, Kathrin
Helmer, Carina
Bielenberg, Wiebke
grosse Beilage, Elisabeth
Schwemmle, Martin
Beer, Martin https://orcid.org/0000-0002-0598-5254
Harder, Timm https://orcid.org/0000-0003-2387-378X
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DFG-434507207, DFG-434507207, DFG-434507207)
ICRAD - International Coordination of Research on Infectious Animal Diseases
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (IZCOZO_189903, IZCOZO_189903)
Article History
Received: 24 February 2024
Accepted: 24 June 2024
First Online: 13 July 2024
Competing interests
: G.Z. and A.S. filed a patent related to the use of RNA replicon-based influenza vaccines. All other authors declare no financial or non-financial competing interests.